TRUALT BIOENERGY LIMITED

TRUALT BIOENERGY LIMITED

TRUALTNSE / BSEEnergySmall Cap

₹360.30-₹14.80 (-3.9%)

Last close · Data as of Oct 30, 2026

Market cap
₹3,168 Cr
P/E
27.6x
EV / EBITDA
19.1x
Revenue
₹1,880 Cr
Net margin
2.9%
ROCE
9.8%

-21.0% over the last year

TRUALT BIOENERGY LIMITED price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 9 moving averages, RSI, MACD and drawing tools

Open technical chart
Open technical chartCandles, 9 moving averages, RSI, MACD, drawing tools

Performance

Price change over each period, before dividends.

1M
-23.0%
3M
-17.3%
6M
-26.7%
1Y
-21.0%
5Y
-32.1%

52-week range

Day change -₹14.80 (-3.9%) from ₹375 to ₹360 · Last close Oct 30, 2026

AI Summary

Indian Stock

Strengths1

  • Revenue grew 54.5% YoY

Concerns1

  • Low interest coverage ratio of 1.3x

Rule-based from financial data. Not advice.

About the company

TruAlt Bioenergy Limited produces and sells biofuels in India. Its products include ethanol, compressed biogas, extra neutral alcohol, and fermented organic manure. The company was formerly known as TruAlt Energy Limited and changed its name to TruAlt Bioenergy Limited in July 2022. TruAlt Bioenergy Limited was incorporated in 2021 and is based in Bengaluru, India.

Sector
Energy
Shares outstanding
8.6 Cr shares
ISIN
INE0MWH01014
BSE code
544545

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
₹3,168 Cr
P/E
27.6x
EV / EBITDA
19.1x
EV / Sales
3.8x
P/S
2.6x
Earnings yield
3.6%
52-week high
₹532.10
52-week low
₹320.05

Profitability

Operating margin
15.4%
Net margin
2.9%
EBITDA margin
20.0%
ROE
13.0%
ROCE
9.8%
ROA
1.5%
Dividend payout
0.0%
Tax rate
27.0%
Other income, % of PBT
119.1%

Growth

Revenue
₹1,880 Cr
Revenue growth, 1Y
54.5%
EBITDA
₹244 Cr
EBITDA growth, 1Y
132.4%
Net profit growth, 1Y
302.9%
Cash from operations
₹28.0 Cr
CFO growth, 1Y
-88.0%
Free cash flow
₹13.0 Cr
Asset growth, 1Y
27.3%

Solvency and efficiency

Current ratio
1.81
Debt / Equity
6.16
Debt / Assets
0.70
Debt / EBITDA
6.79
Interest coverage
1.33
Financial leverage
8.78
CFO / Net profit
0.80
Cash / Market cap
24.1%
Cash per share
₹89.23
Asset turnover
0.52
Fixed asset turnover
0.89
Capital intensity
1.13
Debtor days
89 days
Inventory turnover
5.14
Cash conversion cycle
97 days

Where the revenue went

Of every ₹100 of FY2025 revenue, ₹8 was left as net profit.

TRUALT BIOENERGY LIMITED income statement flow, FY2025
TRUALT BIOENERGY LIMITED income statement flow, FY2025: flows
FromToAmount
SalesExpenses₹1,583 Cr
SalesOperating profit₹297 Cr
Operating profitInterest₹141 Cr
Operating profitDepreciation₹65 Cr
Operating profitProfit before tax₹91 Cr
Other incomeProfit before tax₹61 Cr
Profit before taxTax and other₹11 Cr
Profit before taxNet profit₹141 Cr

Revenue and net profit

Revenue grew 54.5% in FY2025; net profit is the dashed line.

TRUALT BIOENERGY LIMITED revenue and net profit by fiscal year
TRUALT BIOENERGY LIMITED revenue and net profit by fiscal year
DateRevenueNet profit
FY2022₹0 Cr₹0 Cr
FY2023₹762 Cr₹35 Cr
FY2024₹1,217 Cr₹35 Cr
FY2025₹1,880 Cr₹141 Cr

Cash flows

FY2025: ₹336 Cr from operations, ₹79.0 Cr free after investment (dashed).

TRUALT BIOENERGY LIMITED operating and free cash flow by fiscal year
TRUALT BIOENERGY LIMITED operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022₹0 Cr₹0 Cr
FY2023₹233 Cr-₹916 Cr
FY2024₹28 Cr-₹361 Cr
FY2025₹336 Cr₹79 Cr

Growth

Latest fiscal year FY2025 (ending March): each figure with its change over the year before.

Revenue
₹1,880 Cr+54.5%1Y
Net profit
₹141 Cr+302.9%1Y
Cash from operations
₹336 Cr
Free cash flow
₹79 Cr
YearRevenueOperating incomeEBITDANet profitCFOFCFROERevenue growth 1YNet profit growth 1Y
FY2025₹1,880 Cr₹297 Cr—₹141 Cr₹336 Cr₹79 Cr18.4%+54.5%+302.9%

Monthly returns

Month-by-month returns of TRUALT across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Liabilities and equity₹2,978 Cr
Equity capital₹71 Cr
Reserves₹697 Cr
Borrowings₹1,539 Cr
Other liabilities₹671 Cr
Assets₹2,978 Cr
Fixed assets₹1,772 Cr
Capital work in progress₹3 Cr
Investments₹21 Cr
Other assets₹1,182 Cr

Market cap against peers

8 peers: same sector group, nearest by size.

  1. PTC India Ltd₹4,693 Cr
  2. TRUALT BIOENERGY LIMITED (this company)₹3,168 Cr
  3. EMS LIMITED₹2,151 Cr

P/E against peers

TRUALT trades at 27.6x earnings against a peer median of 24.8x (a 11% premium).

Not shown (no positive earnings and no EV / Sales): Prabha Energy Limited.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
TRUALT BIOENERGY LIMITEDTRUALTthis companyP/E ↑ premium₹3,168 Cr27.6x—13.0%19.1x
STERLING AND WILSON RENEWABLE ENERGY LIMITEDSWSOLAR₹4,730 Cr15.6x10.1x3.2%12.6x
PTC India LtdPTC₹4,693 Cr10.8x1.0x8.9%7.2x
ELLENBARRIE INDUSTRIAL GASES LIMITEDELLEN₹3,959 Cr45.4x4.3x11.0%49.4x
GK ENERGY LIMITEDGKENERGY₹2,857 Cr19.6x3.7x64.3%52.3x
INSOLATION ENERGY LIMITEDINA₹2,766 Cr41.1x6.3x5.9%348.0x
Deep Industries LimitedDEEPINDS₹2,416 Cr14.5x1.7x8.3%14.0x
Prabha Energy LimitedPRABHA₹2,288 Cr—5.3x-0.2%-2284.2x
EMS LIMITEDEMSLIMITED₹2,151 Cr13.3x2.1x19.1%9.5x
Peer median—24.8x3.1x12.8%15.7x

Year-to-date ROI

TRUALT since 1 January, against earlier years.

Historical volatility

TRUALT's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, in ₹ crore, grouped into plain-language lines.

Figures in ₹ crore as reported, fiscal years ending March, newest first; the trailing twelve months (TTM) last.

Operating margin by fiscal year

TRUALT BIOENERGY LIMITED operating margin by fiscal year
TRUALT BIOENERGY LIMITED operating margin by fiscal year
DateOperating margin
FY202314.0%
FY202415.0%
FY202516.0%
LineFY2025
RevenueSales₹1,880 Cr
Costs
Interest₹141 Cr
Expenses₹1,583 Cr
Profit before tax₹152 Cr

Learn while you research

Academy chapters picked for TRUALT BIOENERGY LIMITED and the metrics on this page.

  1. 01 Taxes on Investments (India)LTCG, STCG, dividend tax, what every Indian investor needs.6 min read
  2. 02 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  3. 03 Growth Investing54% revenue growth is in the top tier, learn how to value growth.7 min read
  4. 04 Leverage RatiosDebt/Equity of 6.16 is elevated, understand what that means for solvency.6 min read
  5. 05 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  6. 06 Business Cycles & StocksThese cyclical sectors win and lose in different macro phases.6 min read
Browse the full Equiscale Academy →